Researchers use the skill to annotate protein variants with structural observations and literature connections during drug discovery. This helps identify potential drug targets and assess variant impacts on protein function, streamlining early-stage research.

Clinical geneticists submit annotations on variant clinical significance to document pathogenicity or drug response. This supports variant interpretation in diagnostic labs, aiding in patient reports and treatment decisions.

Scientists and students annotate variants with methodology notes and cross-variant patterns for collaborative projects. This facilitates data sharing and peer review in academic studies on protein structures and diseases.

Bioinformaticians use the skill to submit corrections and general observations on variant datasets. This improves data quality and integrates agent findings into larger analysis pipelines for genomic research.

Teams annotate variants with drug target assessments to evaluate existing drugs for new indications. This accelerates repurposing efforts and identifies safety risks related to protein mutations in clinical trials.

Offer tiered subscriptions for access to the Clarity Protocol API, with higher tiers providing increased rate limits and priority support. Revenue comes from monthly or annual fees charged to research institutions and companies.

License aggregated annotation data to pharmaceutical firms and academic consortia for use in proprietary research. Generate revenue through one-time licensing fees or usage-based charges for data access and analytics reports.

Provide consulting services to help organizations integrate the skill into their workflows, including custom annotation types and API key management. Revenue is earned through project-based fees and ongoing support contracts.